Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Womack

Foot and Ankle Surgery Greenville, SC Medical Doctor

NPI 1366579666 CMS profile 243099

35 International Dr, Greenville, SC 29615

Open in the dashboard

General payments

$95,985

278 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Womack of Greenville, SC is reported in the CMS Open Payments database as having received $95,985 across 278 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Foot and Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,002 43
2024 General $21,089 52
2023 General $29,644 76
2022 General $19,792 39
2021 General $1,852 24
2020 General $573 6
2019 General $4,032 38

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Womack
  • Foot and Ankle Surgery median
  • Middle half of Foot and Ankle Surgery
  • National median

In program year 2025, general payments to John Womack were reported at $19,002. Among 650 Foot and Ankle Surgery profiles paid that year, the median was $1,183 and the middle half received between $267 and $6,309.

Show as a table
Year John Womack Foot and Ankle Surgery median Middle half National median
2019 $4,032 $1,327 $279–$5,421 $163
2020 $573 $795 $121–$3,473 $114
2021 $1,852 $1,289 $201–$4,963 $132
2022 $19,792 $1,539 $270–$6,067 $149
2023 $29,644 $1,117 $257–$5,264 $160
2024 $21,089 $1,064 $235–$4,944 $164
2025 $19,002 $1,183 $267–$6,309 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $42,659 130 payments
  2. Smith+Nephew, Inc. $34,510 48 payments
  3. Arthrex, Inc. $10,382 51 payments
  4. Peerless Surgical Inc. $7,250 24 payments
  5. Wright Medical Technology, Inc. $445 12 payments
  6. Medtronic, Inc. $169 1 payment
  7. Treace Medical Concepts, Inc. $153 2 payments
  8. Sanara MedTech Inc. $145 1 payment
  9. Medical Device Business Services, Inc. $122 1 payment
  10. AbbVie, Inc. $61 4 payments
  11. Other $90 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $41,673 19 payments
  2. Travel and Lodging $24,812 68 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $20,800 8 payments
  4. Food and Beverage $7,476 182 payments
  5. Education $1,225 1 payment
Products named General payments · program years 2019–2025
  1. PROSTEP $35,593 36 payments
  2. PROPHECY $16,467 14 payments
  3. Bone Anchors with Arthroscopic Delivery System $14,464 13 payments
  4. Bioinductive Implant with Arthroscopic Delivery System - Medium $11,193 7 payments
  5. PROSTEP MICA $4,023 12 payments
  6. HEALICOIL $3,942 4 payments
  7. Q-FIX $3,300 1 payment
  8. FOOTPRINT $3,300 1 payment
  9. MAXLOCK EXTREME $2,145 1 payment
  10. AUGMENT INJECTABLE $1,630 6 payments
  11. Other $14,793 100 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

251

Median for Orthopedic Surgery: 203

Drug cost

$1,003

Median for Orthopedic Surgery: $1,433

Branded share of claims

6.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methylprednisolone Generic 85 $383
Oxycodone Hcl Generic 48 $216
Cephalexin Generic 49 $164
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 16 $140
Meloxicam Generic 53 $101

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 95 billing codes

Paid by Medicare

$257,127

Of which drugs: $906

Medicare patients

615

Average age 73

Services billed

9,184

411 women, 204 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 68%
Arthritis 67%
Ischemic heart disease 25%
Depression 25%
Diabetes 20%
Chronic kidney disease 18%
Osteoporosis 18%
Atrial fibrillation 12%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 68 6,882 $704
Injection, methylprednisolone acetate, 40 mg J1030 Office 25 50 $201

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

278 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Foot and Ankle Surgery in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record